Skip to main content
Erschienen in: European Spine Journal 4/2013

01.06.2013 | Review Article

Factors that influence current tuberculosis epidemiology

verfasst von: Juan-Pablo Millet, Antonio Moreno, Laia Fina, Lucía del Baño, Angels Orcau, Patricia García de Olalla, Joan A. Caylà

Erschienen in: European Spine Journal | Sonderheft 4/2013

Einloggen, um Zugang zu erhalten

Abstract

According to WHO estimates, in 2010 there were 8.8 million new cases of tuberculosis (TB) and 1.5 million deaths. TB has been classically associated with poverty, overcrowding and malnutrition. Low income countries and deprived areas, within big cities in developed countries, present the highest TB incidences and TB mortality rates. These are the settings where immigration, important social inequalities, HIV infection and drug or alcohol abuse may coexist, all factors strongly associated with TB. In spite of the political, economical, research and community efforts, TB remains a major global health problem worldwide. Moreover, in this new century, new challenges such as multidrug-resistance extension, migration to big cities and the new treatments with anti-tumour necrosis alpha factor for inflammatory diseases have emerged and threaten the decreasing trend in the global number of TB cases in the last years. We must also be aware about the impact that smoking and diabetes pandemics may be having on the incidence of TB. The existence of a good TB Prevention and Control Program is essential to fight against TB. The coordination among clinicians, microbiologists, epidemiologists and others, and the link between surveillance, control and research should always be a priority for a TB Program. Each city and country should define their needs according to the epidemiological situation. Local TB control programs will have to adapt to any new challenge that arises in order to respond to the needs of their population.
Literatur
2.
Zurück zum Zitat Keshavjee S, Harrington M, Gonsalves G, Chesire L, Farmer PE (2011) Time for zero deaths from tuberculosis. Lancet 378(9801):1449–1450PubMedCrossRef Keshavjee S, Harrington M, Gonsalves G, Chesire L, Farmer PE (2011) Time for zero deaths from tuberculosis. Lancet 378(9801):1449–1450PubMedCrossRef
3.
Zurück zum Zitat Shaw JB, Wynn-Williams N (1954) Infectivity of pulmonary tuberculosis in relation to sputum status. Am Rev Tuberc 69(5):724–732PubMed Shaw JB, Wynn-Williams N (1954) Infectivity of pulmonary tuberculosis in relation to sputum status. Am Rev Tuberc 69(5):724–732PubMed
4.
Zurück zum Zitat Grzybowski S, Barnett GD, Styblo K (1975) Contacts of cases of active pulmonary tuberculosis. Bull Int Union Tuberc 50(1):90–106PubMed Grzybowski S, Barnett GD, Styblo K (1975) Contacts of cases of active pulmonary tuberculosis. Bull Int Union Tuberc 50(1):90–106PubMed
5.
Zurück zum Zitat van Geuns HA, Meijer J, Styblo K (1975) Results of contact examination in Rotterdam, 1967–1969. Bull Int Union Tuberc 50(1):107–121PubMed van Geuns HA, Meijer J, Styblo K (1975) Results of contact examination in Rotterdam, 1967–1969. Bull Int Union Tuberc 50(1):107–121PubMed
6.
Zurück zum Zitat Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC (1999) Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282(7):677–686PubMedCrossRef Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC (1999) Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282(7):677–686PubMedCrossRef
7.
Zurück zum Zitat Advisory Council for the Elimination of Tuberculosis (ACET) (1999) Tuberculosis elimination revisited: obstacles, opportunities, and a renewed commitment. MMWR Recomm Rep 48(RR-9):1–13 Advisory Council for the Elimination of Tuberculosis (ACET) (1999) Tuberculosis elimination revisited: obstacles, opportunities, and a renewed commitment. MMWR Recomm Rep 48(RR-9):1–13
8.
Zurück zum Zitat Institute of Medicine (US) Committee on the Elimination of Tuberculosis in the United States (2000) Endling neglect: the elimination of tuberculosis in the United States, National Academy Press, Washington, DC Institute of Medicine (US) Committee on the Elimination of Tuberculosis in the United States (2000) Endling neglect: the elimination of tuberculosis in the United States, National Academy Press, Washington, DC
9.
Zurück zum Zitat Orcau À, Caylà JA, Martínez JA (2011) Present epidemiology of tuberculosis. Prevention and control programs. Enferm Infecc Microbiol Clin Suppl 1:2–7CrossRef Orcau À, Caylà JA, Martínez JA (2011) Present epidemiology of tuberculosis. Prevention and control programs. Enferm Infecc Microbiol Clin Suppl 1:2–7CrossRef
10.
Zurück zum Zitat Houshian S, Poulsen S, Riegels-Nielsen P (2000) Bone and joint tuberculosis in Denmark: increase due to immigration. Acta Orthop Scand 71(3):312–315PubMedCrossRef Houshian S, Poulsen S, Riegels-Nielsen P (2000) Bone and joint tuberculosis in Denmark: increase due to immigration. Acta Orthop Scand 71(3):312–315PubMedCrossRef
11.
Zurück zum Zitat Forssbohm M, Zwahlen M, Loddenkemper R, Rieder HL (2008) Demographic characteristics of patients with extrapulmonary tuberculosis in Germany. Eur Respir J 31(1):99–105PubMedCrossRef Forssbohm M, Zwahlen M, Loddenkemper R, Rieder HL (2008) Demographic characteristics of patients with extrapulmonary tuberculosis in Germany. Eur Respir J 31(1):99–105PubMedCrossRef
12.
Zurück zum Zitat Talbot JC, Bismil Q, Saralaya D, Newton DA, Frizzel RM, Shaw DL (2007) Musculoskeletal tuberculosis in Bradford—a 6-year review. Ann R Coll Surg Engl 89(4):405–409PubMedCrossRef Talbot JC, Bismil Q, Saralaya D, Newton DA, Frizzel RM, Shaw DL (2007) Musculoskeletal tuberculosis in Bradford—a 6-year review. Ann R Coll Surg Engl 89(4):405–409PubMedCrossRef
13.
Zurück zum Zitat García-Lechuz JM, Julve R, Alcala L, Ruíz-Serrano MJ, Muñoz P (2002) Espondilodiscitis tuberculosa o enfermedad de Pott: experiencia en un hospital general. Enferm Infecc Microbiol Clin 20(1):5–9PubMedCrossRef García-Lechuz JM, Julve R, Alcala L, Ruíz-Serrano MJ, Muñoz P (2002) Espondilodiscitis tuberculosa o enfermedad de Pott: experiencia en un hospital general. Enferm Infecc Microbiol Clin 20(1):5–9PubMedCrossRef
14.
Zurück zum Zitat United Nations, Department of Economic and Social Affairs, Population Division (2009) Trends in International Migrant Stock: the 2008 revision (United Nations database, POP/DB/MIG/Stock/Rev.2008) United Nations, Department of Economic and Social Affairs, Population Division (2009) Trends in International Migrant Stock: the 2008 revision (United Nations database, POP/DB/MIG/Stock/Rev.2008)
15.
Zurück zum Zitat Rieder HL, Zellweger JP, Raviglione MC, Keizer ST, Migliori GB (1994) Tuberculosis control in Europe and international migration. Eur Respir J 7:1545–1553PubMedCrossRef Rieder HL, Zellweger JP, Raviglione MC, Keizer ST, Migliori GB (1994) Tuberculosis control in Europe and international migration. Eur Respir J 7:1545–1553PubMedCrossRef
16.
Zurück zum Zitat Tuberculosis Surveillance Report in Europe 2009. European Centre for Disease Prevention and Control (ECDC) and WHO regional office for Europe Tuberculosis Surveillance Report in Europe 2009. European Centre for Disease Prevention and Control (ECDC) and WHO regional office for Europe
17.
Zurück zum Zitat Marin M, Moreno R, Gil M, Bueso MJ, Romeu MA, Gonzalez F (2010) Impacto de la inmigración desde Rumanía en la tuberculosis de un area mediterránea. Enf Emerg 12:115–120 Marin M, Moreno R, Gil M, Bueso MJ, Romeu MA, Gonzalez F (2010) Impacto de la inmigración desde Rumanía en la tuberculosis de un area mediterránea. Enf Emerg 12:115–120
18.
Zurück zum Zitat Cayla JA, Orcau A Control of tuberculosis in large cities in developed countries: an organisational problem. BMC Medicine (in press) Cayla JA, Orcau A Control of tuberculosis in large cities in developed countries: an organisational problem. BMC Medicine (in press)
19.
Zurück zum Zitat Bothamley GH, Kruijshaar ME, Kunst H, Woltmann G, Cotton M, Saralaya D, Woodhead MA, Watson JP, Chapman ALN. Tuberculosis in UK cities: workload and effectiveness of TB control programmes. BMC Public Health (in press) Bothamley GH, Kruijshaar ME, Kunst H, Woltmann G, Cotton M, Saralaya D, Woodhead MA, Watson JP, Chapman ALN. Tuberculosis in UK cities: workload and effectiveness of TB control programmes. BMC Public Health (in press)
20.
Zurück zum Zitat Tuberculosis in the UK. Report on tuberculosis surveillance in the UK 2010 Health Protection Agency Tuberculosis in the UK. Report on tuberculosis surveillance in the UK 2010 Health Protection Agency
21.
Zurück zum Zitat Gatell JM, Zulaica D, Del Romero J (2010) Cómo promover y facilitar el diagnóstico precoz de la infección por el VIH-1. Enf Emerg 12:121–124 Gatell JM, Zulaica D, Del Romero J (2010) Cómo promover y facilitar el diagnóstico precoz de la infección por el VIH-1. Enf Emerg 12:121–124
22.
Zurück zum Zitat Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS et al (1989) A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 320:545–550PubMedCrossRef Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS et al (1989) A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 320:545–550PubMedCrossRef
23.
Zurück zum Zitat Getahun H, Gunneberg C, Granich R, Nunn P (2010) HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis 50(Suppl 3):S201–S207PubMedCrossRef Getahun H, Gunneberg C, Granich R, Nunn P (2010) HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis 50(Suppl 3):S201–S207PubMedCrossRef
24.
Zurück zum Zitat Decker CF, Masur H (1994) Current status of prophylaxis for opportunistic infections in HIV-infected patients. AIDS 8:11–20PubMedCrossRef Decker CF, Masur H (1994) Current status of prophylaxis for opportunistic infections in HIV-infected patients. AIDS 8:11–20PubMedCrossRef
25.
Zurück zum Zitat Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Schooley RT et al (1987) The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med 317:185–191PubMedCrossRef Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Schooley RT et al (1987) The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med 317:185–191PubMedCrossRef
26.
Zurück zum Zitat Leroy V, Salmi LR, Dupon M, Sentilhes A, Texier-Maugein J, Dequae L, Dabis F, Salamon R (1997) A cohort study in Bordeaux, France, 1988–1994. The Groupe d’Epidémiologie Clinique du Sida en Aquitaine (GECSA). Am J Epidemiol 15:293–300CrossRef Leroy V, Salmi LR, Dupon M, Sentilhes A, Texier-Maugein J, Dequae L, Dabis F, Salamon R (1997) A cohort study in Bordeaux, France, 1988–1994. The Groupe d’Epidémiologie Clinique du Sida en Aquitaine (GECSA). Am J Epidemiol 15:293–300CrossRef
27.
Zurück zum Zitat Pablos-Méndez A, Sterling TR, Frieden TR (1996) The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. JAMA 276:1223–1228PubMedCrossRef Pablos-Méndez A, Sterling TR, Frieden TR (1996) The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. JAMA 276:1223–1228PubMedCrossRef
28.
Zurück zum Zitat García de Olalla P, Martínez-González MA, Caylà JA, Jansà JM, Iglesias B, Guerrero R, Marco A, Gatell JM, Ocaña I, Barcelona AIDS–TB Study Group (2002) Influence of highly active anti-retroviral therapy (HAART) on the natural history of extra-pulmonary tuberculosis in HIV patients. Int J Tuberc Lung Dis 6:1051–1057PubMed García de Olalla P, Martínez-González MA, Caylà JA, Jansà JM, Iglesias B, Guerrero R, Marco A, Gatell JM, Ocaña I, Barcelona AIDS–TB Study Group (2002) Influence of highly active anti-retroviral therapy (HAART) on the natural history of extra-pulmonary tuberculosis in HIV patients. Int J Tuberc Lung Dis 6:1051–1057PubMed
29.
Zurück zum Zitat Leonard MK, Larsen N, Drechsler H et al (2002) Increased survival of persons with tuberculosis and human immunodeficiency virus infection, 1991–2000. Clin Infect Dis 34:1002–1007PubMedCrossRef Leonard MK, Larsen N, Drechsler H et al (2002) Increased survival of persons with tuberculosis and human immunodeficiency virus infection, 1991–2000. Clin Infect Dis 34:1002–1007PubMedCrossRef
30.
Zurück zum Zitat Thseng SH, Shyong-Jiang DD, Hoi HS, Lo HY, Hwang KP (2009) Effect of free treatment and surveillance on HIV-infected persons who have tuberculosis, Taiwan, 1993–2006. Emerg Infect Dis 15:332–334CrossRef Thseng SH, Shyong-Jiang DD, Hoi HS, Lo HY, Hwang KP (2009) Effect of free treatment and surveillance on HIV-infected persons who have tuberculosis, Taiwan, 1993–2006. Emerg Infect Dis 15:332–334CrossRef
31.
Zurück zum Zitat Hung CC, Chen MY, Hsiao CF, Hsieh SM, Sheng WH, Chang SC (2003) Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy. AIDS 17:2615–2622PubMedCrossRef Hung CC, Chen MY, Hsiao CF, Hsieh SM, Sheng WH, Chang SC (2003) Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy. AIDS 17:2615–2622PubMedCrossRef
32.
Zurück zum Zitat Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS et al (1989) A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 320(9):545–550PubMedCrossRef Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS et al (1989) A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 320(9):545–550PubMedCrossRef
33.
Zurück zum Zitat Deiss RG, Rodwell TC, Garfein RS (2009) Tuberculosis and illicit drug use: review and update. Clin Infect Dis 48(1):72–82PubMedCrossRef Deiss RG, Rodwell TC, Garfein RS (2009) Tuberculosis and illicit drug use: review and update. Clin Infect Dis 48(1):72–82PubMedCrossRef
36.
Zurück zum Zitat Shafey O, Eriksen M, Ross H, Mackay J (2009) El atlas del tabaco. Sociedad Americana del Cáncer 3:18–21 Shafey O, Eriksen M, Ross H, Mackay J (2009) El atlas del tabaco. Sociedad Americana del Cáncer 3:18–21
38.
Zurück zum Zitat Leung CM, Leung KC, Hon KE, Kong AY (2009) Fighting tobacco smoking—a difficult but not impossible battle. Int J Environ Res Public Health 6:69–83PubMedCrossRef Leung CM, Leung KC, Hon KE, Kong AY (2009) Fighting tobacco smoking—a difficult but not impossible battle. Int J Environ Res Public Health 6:69–83PubMedCrossRef
39.
Zurück zum Zitat World Health Organization (2007) The Union against tuberculosis and lung diseases. A WHO/The Union monograph on TB and tobacco control: joining efforts to control two related global epidemics; WHO/HTM/TB/2007.390:21–23 World Health Organization (2007) The Union against tuberculosis and lung diseases. A WHO/The Union monograph on TB and tobacco control: joining efforts to control two related global epidemics; WHO/HTM/TB/2007.390:21–23
40.
Zurück zum Zitat Alcaide J, Altet MN, Plans P, Parrón I, Folguera L, Saltó E, Domínguez A, Pardell H, Salleras L (1996) Cigarette smoking as a risk factor for tuberculosis in young adults: a case–control study. Tuber Lung Dis 77:112–116PubMedCrossRef Alcaide J, Altet MN, Plans P, Parrón I, Folguera L, Saltó E, Domínguez A, Pardell H, Salleras L (1996) Cigarette smoking as a risk factor for tuberculosis in young adults: a case–control study. Tuber Lung Dis 77:112–116PubMedCrossRef
41.
Zurück zum Zitat Leng CC, Li T, Lam TH, Yew WW, Law WS, Tam CM, Chan WM, Chan CK, Ho KS, Chang KC (2004) Smoking and tuberculosis among the elderly in Hong Kong. Am J Respir Crit Care Med 170:1027–1033CrossRef Leng CC, Li T, Lam TH, Yew WW, Law WS, Tam CM, Chan WM, Chan CK, Ho KS, Chang KC (2004) Smoking and tuberculosis among the elderly in Hong Kong. Am J Respir Crit Care Med 170:1027–1033CrossRef
42.
Zurück zum Zitat Lienhardt C, Fielding K, Sillah JS, Bah B, Gustafson P, Warndorff D, Palayew M, Lisse I, Donkor S, Diallo S, Manneh K, Adegbola A, Aaby P, Bah-Sow O, Bennett S, McAdam K (2005) Investigation of the risk factors for tuberculosis: a case–control study in three countries in West Africa. Int J Epidemiol 34:914–923PubMedCrossRef Lienhardt C, Fielding K, Sillah JS, Bah B, Gustafson P, Warndorff D, Palayew M, Lisse I, Donkor S, Diallo S, Manneh K, Adegbola A, Aaby P, Bah-Sow O, Bennett S, McAdam K (2005) Investigation of the risk factors for tuberculosis: a case–control study in three countries in West Africa. Int J Epidemiol 34:914–923PubMedCrossRef
43.
Zurück zum Zitat Lin HH, Ezzati M, Chang HY, Murray M (2009) Association between tobacco smoking and active tuberculosis in Taiwan. Prospective cohort study. Am J Respir Crit Care Med 180:475–480PubMedCrossRef Lin HH, Ezzati M, Chang HY, Murray M (2009) Association between tobacco smoking and active tuberculosis in Taiwan. Prospective cohort study. Am J Respir Crit Care Med 180:475–480PubMedCrossRef
44.
Zurück zum Zitat Jee SH, Golub JE, Jo J, LlS Park, Ohrr H, Samet JM (2009) Smoking and risk of tuberculosis incidence, mortality, and recurrence in South Korean men and women. Am J Epidemiol 170:1478–1485PubMedCrossRef Jee SH, Golub JE, Jo J, LlS Park, Ohrr H, Samet JM (2009) Smoking and risk of tuberculosis incidence, mortality, and recurrence in South Korean men and women. Am J Epidemiol 170:1478–1485PubMedCrossRef
45.
Zurück zum Zitat Slama K, Chiang CY, Enarson DA, Hassmiller Fanning A, Gupta P, Ray C (2007) Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis 11:1049–1061PubMed Slama K, Chiang CY, Enarson DA, Hassmiller Fanning A, Gupta P, Ray C (2007) Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis 11:1049–1061PubMed
46.
Zurück zum Zitat Lin HH, Ezzati M, Murray M (2007) Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLoS Med 4(1):e20PubMedCrossRef Lin HH, Ezzati M, Murray M (2007) Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLoS Med 4(1):e20PubMedCrossRef
47.
Zurück zum Zitat Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR (2007) Risk of tuberculosis from exposure to tobacco smoke. A systematic review and meta-analysis. Arch Intern Med 167:335–342PubMedCrossRef Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR (2007) Risk of tuberculosis from exposure to tobacco smoke. A systematic review and meta-analysis. Arch Intern Med 167:335–342PubMedCrossRef
48.
Zurück zum Zitat den Boon S, Verver S, Marais BJ, Enarson DA, Lombard CJ, Bateman ED, Irusen E, Jithoo A, Gie RP, Borgdorff MW, Beyers N (2007) Association between passive smoking and infection with Mycobacterium tuberculosis in children. Pediatrics 119(4):734–739CrossRef den Boon S, Verver S, Marais BJ, Enarson DA, Lombard CJ, Bateman ED, Irusen E, Jithoo A, Gie RP, Borgdorff MW, Beyers N (2007) Association between passive smoking and infection with Mycobacterium tuberculosis in children. Pediatrics 119(4):734–739CrossRef
49.
Zurück zum Zitat Leung CC, Lam TH, Ho KS, Yew WW, Tam CM, Chan WM, Law WS, Chan CK, Chang KC, Au KF (2010) Passive smoking and tuberculosis. Arch Intern Med 170(3):287–292PubMedCrossRef Leung CC, Lam TH, Ho KS, Yew WW, Tam CM, Chan WM, Law WS, Chan CK, Chang KC, Au KF (2010) Passive smoking and tuberculosis. Arch Intern Med 170(3):287–292PubMedCrossRef
50.
Zurück zum Zitat Altet MN, Alcaide J, Plans P, Taberner JL, Saltó E, Ll Folguera et al (1996) Passive smoking and risk of pulmonary tuberculosis in children immediately following infection. A case–control study. Tub Lung Dis 77:537–544CrossRef Altet MN, Alcaide J, Plans P, Taberner JL, Saltó E, Ll Folguera et al (1996) Passive smoking and risk of pulmonary tuberculosis in children immediately following infection. A case–control study. Tub Lung Dis 77:537–544CrossRef
51.
Zurück zum Zitat Singh M, Mynak ML, Kumar L, Mathew JL, Jindal SK (2005) Prevalence and risk factors for transmission of infection among children in household contact with adults having pulmonary tuberculosis. Arch Dis Child 90(6):624–628PubMedCrossRef Singh M, Mynak ML, Kumar L, Mathew JL, Jindal SK (2005) Prevalence and risk factors for transmission of infection among children in household contact with adults having pulmonary tuberculosis. Arch Dis Child 90(6):624–628PubMedCrossRef
53.
Zurück zum Zitat Sharma SK, Mohan A (2006) Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control. Chest 130:162–272 Sharma SK, Mohan A (2006) Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control. Chest 130:162–272
57.
Zurück zum Zitat Chan ED, Iseman MD (2008) Multidrug-resistant and extensively drug-resistant tuberculosis: a review. Curr Opin Infect Dis 21:587–595PubMedCrossRef Chan ED, Iseman MD (2008) Multidrug-resistant and extensively drug-resistant tuberculosis: a review. Curr Opin Infect Dis 21:587–595PubMedCrossRef
58.
Zurück zum Zitat Ruiz-Manzano J, Blanquer R, Calpe JL, Caminero JA, Caylà J, Domínguez JA, García JM, Vidal R (2008) Diagnóstico y tratamiento de la tuberculosis. Normativa SEPAR. Arch Bronconeumol 44:551–566PubMedCrossRef Ruiz-Manzano J, Blanquer R, Calpe JL, Caminero JA, Caylà J, Domínguez JA, García JM, Vidal R (2008) Diagnóstico y tratamiento de la tuberculosis. Normativa SEPAR. Arch Bronconeumol 44:551–566PubMedCrossRef
59.
Zurück zum Zitat Sarkar S, Suresh MR (2011) An overview of tuberculosis chemotherapy—a literature review. J Pharm Pharmaceut Sci 14:148–161 Sarkar S, Suresh MR (2011) An overview of tuberculosis chemotherapy—a literature review. J Pharm Pharmaceut Sci 14:148–161
60.
Zurück zum Zitat Singla R, Caminero JA, Jaswal A, Singla N, Gupta S, Bali RK, Behera D (2011) Linezolid, an effective, safe and cheap drug in MDR-TB treatment failure in India. Eur Respir J (Epub ahead of print) Singla R, Caminero JA, Jaswal A, Singla N, Gupta S, Bali RK, Behera D (2011) Linezolid, an effective, safe and cheap drug in MDR-TB treatment failure in India. Eur Respir J (Epub ahead of print)
61.
Zurück zum Zitat Amaral L, Boeree MJ, Gillespie SH, Udwadia ZF, van Soonlingen D (2010) Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now! Int J Antimicrobiol Agents 35:524–526CrossRef Amaral L, Boeree MJ, Gillespie SH, Udwadia ZF, van Soonlingen D (2010) Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now! Int J Antimicrobiol Agents 35:524–526CrossRef
62.
Zurück zum Zitat Our motto. Health News. February 1914;30:table of contents. Monthly Bulletin: New York State Department of Health Our motto. Health News. February 1914;30:table of contents. Monthly Bulletin: New York State Department of Health
63.
64.
Zurück zum Zitat Reichman LB (1991) The U shaped curve of concern. Am Rev Resp Dis 148:741–742 Reichman LB (1991) The U shaped curve of concern. Am Rev Resp Dis 148:741–742
65.
Zurück zum Zitat Frieden TR, Fujiwara PI, Washko RM, Hamburg MA (1995) Tuberculosis in New York city—turning the tide. N Engl J Med 333(4):229–233PubMedCrossRef Frieden TR, Fujiwara PI, Washko RM, Hamburg MA (1995) Tuberculosis in New York city—turning the tide. N Engl J Med 333(4):229–233PubMedCrossRef
67.
Zurück zum Zitat Marco A, Caylà JA, Serra M, Pedro R, Sanrama C, Guerrero R, Ribot N (1998) Predictors of adherence to tuberculosis treatment in a supervised therapy programme for prisoners before and after release. Study Group of Adherence to Tuberculosis Treatment of Prisoners. Eur Respir J 4:967–971CrossRef Marco A, Caylà JA, Serra M, Pedro R, Sanrama C, Guerrero R, Ribot N (1998) Predictors of adherence to tuberculosis treatment in a supervised therapy programme for prisoners before and after release. Study Group of Adherence to Tuberculosis Treatment of Prisoners. Eur Respir J 4:967–971CrossRef
68.
Zurück zum Zitat Ospina JE, Orcau A, Millet JP, Caylà JA, Casals M, Rius C, Sanchez F (2009) Effectiveness of community health workers for the control of tuberculosis. Int J Tubec Lung Dis 13(12) suppl 1 (Abstract book. 40th World Conference on Lung Health of the IUATL) Ospina JE, Orcau A, Millet JP, Caylà JA, Casals M, Rius C, Sanchez F (2009) Effectiveness of community health workers for the control of tuberculosis. Int J Tubec Lung Dis 13(12) suppl 1 (Abstract book. 40th World Conference on Lung Health of the IUATL)
69.
Zurück zum Zitat Rodrigo T, Caylà JA, Galdós-Tangüis H, García de Olalla P, Brugal MT, Jansà JM (2001) Proposing indicators for evaluation of tuberculosis control programmes in large cities based on the experience of Barcelona. Int J Tuberc Lung Dis 5:432–440PubMed Rodrigo T, Caylà JA, Galdós-Tangüis H, García de Olalla P, Brugal MT, Jansà JM (2001) Proposing indicators for evaluation of tuberculosis control programmes in large cities based on the experience of Barcelona. Int J Tuberc Lung Dis 5:432–440PubMed
70.
Zurück zum Zitat Gillman A, Berggren I, Bergström SE, Wahlgren H, Bennet R (2008) Primary tuberculosis infection in 35 children at a Swedish day care center. Pediatr Infect Dis J 27:1078–1082PubMedCrossRef Gillman A, Berggren I, Bergström SE, Wahlgren H, Bennet R (2008) Primary tuberculosis infection in 35 children at a Swedish day care center. Pediatr Infect Dis J 27:1078–1082PubMedCrossRef
Metadaten
Titel
Factors that influence current tuberculosis epidemiology
verfasst von
Juan-Pablo Millet
Antonio Moreno
Laia Fina
Lucía del Baño
Angels Orcau
Patricia García de Olalla
Joan A. Caylà
Publikationsdatum
01.06.2013
Verlag
Springer-Verlag
Erschienen in
European Spine Journal / Ausgabe Sonderheft 4/2013
Print ISSN: 0940-6719
Elektronische ISSN: 1432-0932
DOI
https://doi.org/10.1007/s00586-012-2334-8

Weitere Artikel der Sonderheft 4/2013

European Spine Journal 4/2013 Zur Ausgabe

Ideas and Technical Innovations

Bone and joint tuberculosis

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Knie-TEP: Kein Vorteil durch antibiotikahaltigen Knochenzement

29.05.2024 Periprothetische Infektionen Nachrichten

Zur Zementierung einer Knie-TEP wird in Deutschland zu über 98% Knochenzement verwendet, der mit einem Antibiotikum beladen ist. Ob er wirklich besser ist als Zement ohne Antibiotikum, kann laut Registerdaten bezweifelt werden.

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.